| This week's sponsor is Premier Research | | | How to Neutralize the Placebo Effect
Placebo response is a natural enemy of any analgesia trial. While it can help, it can also harm. Learn more about this growing phenomenon by catching the start of our 14-part Placebo Problem blogseries. Premier Research. It's what we do. Best. |
Featured Story | | | Friday, September 22, 2017 Versartis’ somavaratan has failed to match Pfizer’s Genotropin in a phase 3 pediatric growth hormone deficiency (pGHD) trial. The potentially company-killing data wiped more than 80% off the biotech’s stock price, leaving it looking to the readout from an ongoing trial in Japan for a shot at redemption. |
|
|
| This week's sponsor is Althea. | | | |
Top Stories Friday, September 22, 2017 AbbVie has joined forces with Bristol-Myers Squibb once again to test an experimental cancer drug with BMS' checkpoint inhibitor Opdivo in the hope of coming up with a new treatment cocktail. Friday, September 22, 2017 Nestlé is beating a retreat from topical dermatology drug R&D. The rethink of R&D priorities is set to cost up to 450 people their jobs and could result in the closure of a R&D facility. Monday, September 18, 2017 For pharma and biotech, in which data is the most valuable asset, industry analysts agree that digital transformation presents an opportunity to realize unprecedented productivity gains and competitive advantage. Friday, September 22, 2017 Intercept has been the presumed leader in a race toward one of the hottest new markets in pharma, the liver disease NASH. But 19 deaths in current Ocaliva patients pose a threat to those hopes, and the med faces a setback in its now-approved indication, too. Thursday, September 21, 2017 A gene therapy delivered to the liver delayed progression and reversed symptoms of early-stage multiple sclerosis in mice. With improvements, the approach could be a potential treatment for the autoimmune disease, which has no cure. Friday, September 22, 2017 The FDA has cleared Cefaly Technology’s device for the treatment of migraine attacks. Getting the FDA nod positions Cefaly to expand use of its external trigeminal nerve stimulation (e-TNS) device beyond preventative situations. Thursday, September 21, 2017 In this week's EuroBiotech Report, phase 3 data send Bavarian Nordic and Nabriva in opposite directions, Immunocore raises $40 million and more. Friday, September 22, 2017 GlaxoSmithKline's former CEO Andrew Witty and former R&D head Moncef Slaoui jumped into biotech venture capital, Aerie poached yet another executive from Novartis' Alcon unit, Roivant Sciences hired a Silicon Valley veteran to run its new clinical trial AI company, plus more hirings, firings and retirings throughout the industry. Friday, September 22, 2017 Pfizer leads Big Pharma's emerging markets growth as GlaxoSmithKline and Eli Lilly lag behind, Fosun is buying a smaller 74% stake in Gland Pharma, Japan's Taiho has inked a $35 million option deal to gain access to Arcus' cancer immunotherapy portfolio and more. Resources Sponsored by: Ashfield Healthcare Join this webinar to learn how to design, deliver, and measure a successful patient support program. Presented by Nareda Mills, Ashfield's SVP of Patient Services in the US, you’ll discover how to improve adherence and improve patient outcomes using 5 key methods. Presented By: PRA Health Sciences Children participating in pediatric clinical trials are included in the contraceptive requirements applied to women of child-bearing potential, creating significant challenges for sponsors, parents, investigators and study staff. Sponsored By: RTI Health Solutions In this webinar, we will introduce the rapidly-evolving within-subject clinical trial (WSCT) methods for early phase evidence generation that require fewer people, less time, and usually less funding than traditional early phase methods. 2nd Strategic Partnerships for Drug Repurposing October 26-27, 2017 | Boston, MA Compliance Certificate and Training for Life Sciences Professionals October 9 -12, 2017 | Newark, NJ CBI’s MedComm 2017 Conference October 26-27, 2017 | San Francisco, CA FierceBiotech 2nd Drug Development Forum September 25-27, 2017 | Boston, MA FierceBiotech Executive Summit- London October 2, 2017 | London 11th Digital Pharma East October 3-6, 2017 | Philadelphia, PA Life Sciences Innovation Awards | Don't Miss This Opportunity Application Deadline: Friday, October 20 at midnight EST Drug Development Boot Camp® 2017 November 15-16, 2017 | Boston, MA | 